Pandemic Insights
Creating public health artificial intelligence technologies that reduce the rates of infection and death during pandemics by changing human behavior.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
Related Content
Pandemic Insights, operating as Resilienci, is a preventive health software firm established in 2020. The company focuses on integrating data and artificial intelligence with human behavior dynamics to help individuals and organizations make informed decisions to curtail the spread of infectious diseases.
The firm's core mission, inspired by the challenges of the COVID-19 pandemic, is to develop solutions that address health disparities, particularly in at-risk communities and developing nations. The company's technology is designed to create a comprehensive view for both consumers and healthcare workers during any pathogen outbreak. By providing real-time data and actionable insights, the company aims to empower communities to reduce infection and mortality rates.
Resilienci offers digital health solutions through mobile and web applications, with plans to incorporate Generative AI to enhance future offerings. The product portfolio includes Rapid-AI, a platform for consumers and public health agencies that uses AI to analyze data and provide preliminary diagnoses, which can then be shared anonymously with healthcare professionals to speed up triage and intervention. The technology sources data from authorities like governments and public health agencies, using proprietary algorithms to assess local pathogen exposure risks. This allows users to make informed choices about their movements and healthcare. A key feature is a commitment to privacy; the company states it tracks pathogens rather than people, anonymizing all user data and possessing patents related to privacy.
The company holds a portfolio of 13 patents globally, with 2 granted and over half of the portfolio active. All patents have been filed in the United States, which is also the company's primary R&D center and country of origin. The business model appears to involve a public-private collaboration approach, aiming to build an interoperable multi-pathogen platform for consumers, healthcare workers, and public health agencies.
Keywords: Resilienci, digital health, infectious disease response, public health technology, pathogen surveillance, AI in healthcare, health equity, risk reduction, hyperlocal data, disease outbreak, preventive health, multi-pathogen platform, consumer health apps, data-driven insights, health disparities, pandemic preparedness, real-time health data, mobile health solutions, community health, patented health tech